Donald Gleason

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

Journal of the National Cancer Institute · 2002 · 1,275 citations

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

Journal of the National Cancer Institute · 2004 · 884 citations